Usually, inhibition of oncogenic TK activity leads to down-regulation of several downstream signaling pathways, including mitogen-activated protein kinase (MAPK) cascades and phosphatidylinositol 3′-kinase (PI3K)/AKT pathway, consequently repressing proliferation, invasion and survival of cancer cells. The gene discussed is AKT1; the disease is cancer.